查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067650

北美動脈外科止血密封劑市場規模、佔有率和趨勢分析報告：按產品、應用和細分市場分類（2026-2033 年）

North America Hemostatic Sealants In Arterial Surgery Market Size, Share & Trends Analysis Report By Product (Fibrin-based Sealants, Synthetic/Polymer-based Sealants), By Application, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

北美動脈外科止血密封劑市場概覽

預計到 2025 年，北美動脈手術用止血密封劑市場規模將達到 1 億美元，並預計從 2026 年的 1.023 億美元成長到 2033 年的 1.196 億美元，2026 年至 2033 年的複合年成長率為 2.3%。

這一成長是由複雜血管手術中對有效術中出血管理的需求不斷增加所驅動的。

動脈手術，例如主動脈瘤修復術、周邊血管搭橋術、頸動脈切除術和血管重建術，由於高血壓以及心血管疾病患者廣泛使用抗凝血治療，常常存在較高的出血風險。因此，醫院和血管外科醫師擴大採用局部止血劑作為輔助技術，以提高手術精確度、減少出血量並改善術後效果。

隨著臨床上越來越重視減少術中併發症、縮短手術時間以及最大限度地減少輸血和再次手術的需求，止血密封劑市場正從中受益。止血密封劑擴大用於加強血管吻合口、封裝針刺出血以及維持動脈修復縫合線的完整性。由於其能夠快速止血，因此在涉及脆弱血管組織或鈣化動脈的手術，以及涉及患有多種合併症的老年患者的高風險手術中，止血密封劑尤其有用。

推動市場擴張的主要動力是臨床證據的積累，這些證據支持血管外科手術中密封劑的有效性。 2024年5月，Cochrane系統性回顧的最新版題為“密封劑在血管外科吻合口止血中的作用”，該評估評估了24項隨機對照試驗，涉及2300多名血管外科患者。分析表明，與傳統的止血方法（如手動壓迫、明膠海綿和氧化纖維素製劑）相比，使用密封劑可顯著縮短止血時間。此評估也強調了止血操作的低失敗率，增強了外科醫師對使用密封劑進行血管閉合技術的信心。

在北美，隨著TISSEEL、EVISEL、BioGlue、COSEAL和SURGIFLO等先進纖維蛋白和合成密封劑產品日益普及，其商業性應用範圍持續擴大。這些產品因其聚合速度快、組織黏附性強、易於使用以及適用於開放式和微創手術等優點，正擴大被醫院和血管外科中心所採用。

美國和加拿大心血管疾病盛行率的不斷上升進一步推動了動脈手術數量的成長。周邊動脈疾病、腹部主動脈血管瘤、糖尿病相關血管併發症、創傷性血管損傷的發生率不斷增加，是血管介入治療需求上升的主要原因。同時，北美人口的快速老化導致需要動脈重組或搭橋手術的老年患者數量不斷增加，從而對先進的術中止血方案提出了更高的要求。

微創主動脈瓣置換術（MIAVR）在心臟中心也正快速普及。美國國家醫學圖書館發表的一項研究表明，與傳統開胸手術相比，MIAVR 可顯著降低術後疼痛、輸血需求、呼吸系統併發症、傷口感染、加護病房（ICU）住院時間和總住院時間。該研究還強調了 MIAVR 可改善患者外觀、促進早期活動恢復以及減輕整體手術負擔。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：北美動脈外科止血密封劑市場：影響因素、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 北美動脈外科止血密封劑市場分析工具

第4章：北美動脈外科止血密封劑市場：基於產品的估算與趨勢分析

  • 北美動脈外科止血密封劑市場：基於產品的波動分析
  • 北美動脈外科止血密封劑市場：按產品和前景分類
  • 市場規模、預測與趨勢分析，2021-2033年
  • 纖維蛋白基密封劑
  • 合成/聚合物密封劑
  • 複方止血劑和密封劑

第5章：北美動脈外科止血密封劑市場：依應用、估算與趨勢分析

  • 北美動脈外科止血密封劑市場：基於應用領域的波動分析
  • 北美動脈外科止血密封劑市場：按應用領域分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 涉及移植物置換的動脈手術
  • 無需使用移植物即可進行動脈修復和重組

第6章：北美動脈外科止血密封劑市場：依適應症分類的估算與趨勢分析

  • 北美動脈外科止血密封劑市場：按適應症分類的波動分析
  • 北美動脈外科止血密封劑市場：依適應症與前景分類
  • 市場規模、預測與趨勢分析，2021-2033年
  • 主動脈瘤
  • 周邊動脈疾病
  • 頸動脈疾病
  • 其他

第7章 北美動脈外科止血密封劑市場：依最終用途分類的估算與趨勢分析

  • 北美動脈外科止血密封劑市場：按最終用途分類的波動分析
  • 北美動脈外科止血密封劑市場：依最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 公立醫院
  • 私立醫院

第8章：北美動脈外科止血密封劑市場：區域細分、預測及趨勢分析

  • 區域儀錶板
  • 北美動脈手術用止血密封劑市場波動分析。
  • 北美動脈外科止血密封劑市場：區域細分、預測及趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大

第9章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • Ethicon
    • Baxter International
    • Corza Medical
    • Integra LifeSciences Corporation
    • Artivion
    • Becton, Dickinson and Company（BD）
    • Teleflex
Product Code: GVR-4-68040-925-6

North America Hemostatic Sealants In Arterial Surgery Market Summary

The North America hemostatic sealants in arterial surgery market size was estimated at USD 100.0 million in 2025 and is projected to grow from USD 102.3 million in 2026 to USD 119.6 million by 2033, at a CAGR of 2.3% from 2026 to 2033. The growth is driven by the increasing demand for effective intraoperative bleeding management during complex vascular procedures.

Arterial surgeries such as aortic aneurysm repair, peripheral bypass grafting, carotid endarterectomy, and vascular reconstruction frequently involve significant bleeding risks due to high-pressure blood flow and the widespread use of anticoagulant therapies among cardiovascular patients. As a result, hospitals and vascular surgeons are increasingly adopting topical hemostatic sealants as adjunctive technologies to enhance surgical precision, reduce blood loss, and improve procedural outcomes.

The market is benefiting from the growing clinical emphasis on reducing operative complications, shortening procedure duration, and minimizing the need for blood transfusions or surgical reinterventions. Hemostatic sealants are increasingly used to reinforce vascular anastomoses, seal needle-hole bleeding, and support suture-line integrity during arterial repair procedures. Their ability to achieve rapid hemostasis has made them particularly valuable in high-risk surgeries involving fragile vascular tissue, calcified arteries, or elderly patients with multiple comorbidities.

A major factor supporting market expansion is the strengthening body of clinical evidence validating the effectiveness of sealants in vascular surgery. In May 2024, an updated Cochrane systematic review titled "The role of sealants for achieving anastomotic hemostasis in vascular surgery" evaluated 24 randomized controlled trials involving more than 2,300 vascular surgery patients. The analysis demonstrated that sealant use significantly reduced time to hemostasis compared with conventional approaches such as manual compression, gelatin sponges, and oxidized cellulose-based agents. The review also highlighted lower rates of hemostatic intervention failure, reinforcing surgeon confidence in sealant-assisted vascular closure techniques.

Commercial adoption across North America continues to expand, driven by the widespread use of advanced fibrin-based and synthetic sealant products, including TISSEEL, EVICEL, BioGlue, COSEAL, and SURGIFLO. These products are increasingly used in hospitals and vascular surgery centers due to their rapid polymerization, strong tissue adhesion, ease of application, and compatibility with both open and minimally invasive surgical approaches.

The rising prevalence of cardiovascular diseases across the U.S. and Canada is further contributing to procedural growth in arterial surgery. Increasing incidences of peripheral artery disease, abdominal aortic aneurysms, diabetes-associated vascular complications, and traumatic vascular injuries are leading to higher volumes of vascular interventions. In parallel, the rapidly aging population across North America is increasing the number of elderly patients requiring arterial reconstruction and bypass procedures, thereby expanding the demand for advanced intraoperative bleeding control solutions.

Minimally invasive aortic valve replacement (MIAVR) procedures are also gaining strong adoption across cardiac centers. A study published by the National Library of Medicine reported that MIAVR significantly reduces postoperative pain, blood transfusion requirements, respiratory complications, wound infections, ICU stays, and hospitalization duration compared to conventional sternotomy procedures. The study further highlighted improved cosmetic outcomes, earlier mobilization, and lower overall surgical trauma.

North America Hemostatic Sealants In Arterial Surgery Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the North America hemostatic sealants in arterial surgery market report based on product, application, disease indication, end use, and country:

  • Product Outlook (Revenue, USD Unit, 2021 - 2033)
  • Fibrin-Based Sealants
  • Synthetic/Polymer-Based Sealants
  • Combination Hemostats & Sealants
  • Application Outlook (Revenue, USD Unit, 2021 - 2033)
  • Arterial Surgery With Graft Replacement
  • Arterial Repair/Reconstruction Without Graft
  • Disease Indication Outlook (Revenue, USD Unit, 2021 - 2033)
  • Aortic Aneurysms
  • Peripheral Artery Disease
  • Carotid Artery Disease
  • Others
  • End Use Outlook (Revenue, USD Unit, 2021 - 2033)
  • Public Hospitals
  • Private Hospitals
  • Country Outlook (Revenue, USD Unit, 2021 - 2033)
  • U.S.
  • Canada

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Disease Indication
    • 1.2.4. End Use
    • 1.2.5. Country scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Disease Indicatio outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Country outlook
  • 2.3. Competitive Insights

Chapter 3. North America Hemostatic Sealants In Arterial Surgery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. North America Hemostatic Sealants In Arterial Surgery Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. North America Hemostatic Sealants In Arterial Surgery Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Hemostatic Sealants In Arterial Surgery Market: Product Movement Analysis
  • 4.3. North America Hemostatic Sealants In Arterial Surgery Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Fibrin-Based Sealants
    • 4.5.1. Fibrin-Based Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Synthetic/Polymer-Based Sealants
    • 4.6.1. Synthetic/Polymer-Based Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Combination Hemostats & Sealants
    • 4.7.1. Combination Hemostats & Sealants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America Hemostatic Sealants In Arterial Surgery Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Hemostatic Sealants In Arterial Surgery Market: Application Movement Analysis
  • 5.3. North America Hemostatic Sealants In Arterial Surgery Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Arterial Surgery With Graft Replacement
    • 5.5.1. Arterial Surgery With Graft Replacement Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Arterial Repair/Reconstruction Without Graft
    • 5.6.1. Arterial Repair/Reconstruction Without Graft Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America Hemostatic Sealants In Arterial Surgery Market: Disease Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America Hemostatic Sealants In Arterial Surgery Market: Disease Indication Movement Analysis
  • 6.3. North America Hemostatic Sealants In Arterial Surgery Market by Disease Indication Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Aortic Aneurysms
    • 6.5.1. Aortic Aneurysms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Peripheral Artery Disease
    • 6.6.1. Peripheral Artery Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Carotid Artery Disease
    • 6.7.1. Carotid Artery Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America Hemostatic Sealants In Arterial Surgery Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America Hemostatic Sealants In Arterial Surgery Market: End Use Movement Analysis
  • 7.3. North America Hemostatic Sealants In Arterial Surgery Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Public Hospitals
    • 7.5.1. Public Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Private Hospitals
    • 7.6.1. Private Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America Hemostatic Sealants In Arterial Surgery Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional North America Hemostatic Sealants In Arterial Surgery Market Movement Analysis
  • 8.3. North America Hemostatic Sealants In Arterial Surgery Market: Regional Estimates & Trend Analysis by Product & Application
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 8.5. North America
    • 8.5.1. North America Hemostatic Sealants In Arterial Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. U.S. Hemostatic Sealants In Arterial Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Canada Hemostatic Sealants In Arterial Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Ethicon
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Baxter International
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Corza Medical
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Integra LifeSciences Corporation
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Artivion
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Becton, Dickinson and Company (BD)
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Teleflex
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Hemostatic Sealants In Arterial Surgery Market, By Country, 2021 - 2033 (USD Million)
  • Table 4 North America Hemostatic Sealants In Arterial Surgery Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 North America Hemostatic Sealants In Arterial Surgery Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 North America Hemostatic Sealants In Arterial Surgery Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 7 North America Hemostatic Sealants In Arterial Surgery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 U.S. Hemostatic Sealants In Arterial Surgery Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 U.S. Hemostatic Sealants In Arterial Surgery Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 U.S. Hemostatic Sealants In Arterial Surgery Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 11 U.S. Hemostatic Sealants In Arterial Surgery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 12 Canada Hemostatic Sealants In Arterial Surgery Market, By Product, 2021 - 2033 (USD Million)
  • Table 13 Canada Hemostatic Sealants In Arterial Surgery Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Hemostatic Sealants In Arterial Surgery Market, By Disease Indication, 2021 - 2033 (USD Million)
  • Table 15 Canada Hemostatic Sealants In Arterial Surgery Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 North America Hemostatic Sealants In Arterial Surgery Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 North America Hemostatic Sealants In Arterial Surgery Market, Product Outlook Key Takeaways (USD Million)
  • Fig. 12 North America Hemostatic Sealants In Arterial Surgery Market: Product Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 13 Fibrin-Based Sealants Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Synthetic/Polymer-Based Sealants Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Combination Hemostats & Sealants Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 North America Hemostatic Sealants In Arterial Surgery Market, Application Outlook Key Takeaways (USD Million)
  • Fig. 17 North America Hemostatic Sealants In Arterial Surgery Market: Application Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 18 Arterial Surgery With Graft Replacement Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Arterial Repair/Reconstruction Without Graft Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 North America Hemostatic Sealants In Arterial Surgery Market, Disease Indication Outlook Key Takeaways (USD Million)
  • Fig. 21 North America Hemostatic Sealants In Arterial Surgery Market: Disease Indication Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 22 Aortic Aneurysms Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Peripheral Artery Disease Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Carotid Artery Disease Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 North America Hemostatic Sealants In Arterial Surgery Market, End Use Outlook Key Takeaways (USD Million)
  • Fig. 27 North America Hemostatic Sealants In Arterial Surgery Market: End Use Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 28 Public Hospitals Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Private Hospitals Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 North America Hemostatic Sealants In Arterial Surgery Market, Regional Key Takeaways (USD Million)
  • Fig. 31 North America Hemostatic Sealants In Arterial Surgery Market Regional Outlook, 2025 & 2033 (USD Million)
  • Fig. 32 North America Hemostatic Sealants In Arterial Surgery Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Hemostatic Sealants In Arterial Surgery Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Canada Hemostatic Sealants In Arterial Surgery Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 List of Key Emerging Company's/Indication Disruptors/Innovators